Being in the 'trial environment' has been very interesting. Clearly there are a lot of very different compounds and approaches being studied right now, which is exciting. It's also pretty clear they still have a lot to learn about cancer and how it all works. It seems they are realising every cancer, and every person, are different. This is only my own observation based on being immersed in the study environment, but there you have it for what it's worth.

But many of these have unworkable bad side effects for a lot of people. They're quite happy with me as I'm doing 'so well' on this trial drug.

Here's hoping it lasts!

47 yr old male non-smoker, social drinker, fit. Jan'10, Stg3 rt tonsil+rt neck SCC, HPV+, rad+chmo Vancouver Cda. 2yr clear Apr'12 London UK. Apr'13 mets recur to lymph btw left lung & aorta, 3x Cisplatin+5FUchemo+20 rad, was all clear but 6-mo PET-CT shows mets to pleura around left lung, participating in St 1 trial of GDC-0980. GDC lost effect and ended July'14, bad atrial fibrillation requiring hospitalisation, start more standard chemo 10 Sep 2014.
Sadly has passed away, notified Jan 2015.